Over 600,000 hypertensive, diabetes patients miss treatment on funding woes
Over 600,000 patients in Kenya missed essential treatments for hypertension and diabetes in the 2024/2025 financial year due to funding shortages. The shortfall represents a significant reversal of progress made in previous years when treatment targets were consistently met.
Why it matters
The funding crisis highlights critical vulnerabilities in public health infrastructure and the potential for rising mortality rates among patients with chronic, manageable conditions.
A total of 626,621 patients with high blood pressure and diabetes missed treatment in the 2024/2025 financial year due to insufficient funding, particularly for essential medications, according to performance data from the Non-Communicable Diseases (NCD) Prevention and Control programme.
The report relies on official performance data and program remarks to explain the decline in service delivery.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in